CCC
HLTH

Crescent Capital Consulting’s Cue Health Inc. Common Stock HLTH Stock Holding History

Crescent Capital Consulting’s Portfolio HLTH Stock Details HLTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$0 Sell
7
-25
-78% -$275 ﹤0.01% 524
2021
Q3 		$0 Buy
+32
New +$504 ﹤0.01% 607

Other funds holding HLTH

KI
Koch Industries Wichita, Kansas $853M AUM 37.49% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
JPC
Jabodon PT Co Reno, Nevada $860M AUM 17.81% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
NCMU
NAYA Capital Management (UK) London, United Kingdom $1.18B AUM 13.14% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

Crescent Capital Consulting's HLTH Position: Q4 2021 in Review

Crescent Capital Consulting reduced its Cue Health Inc. Common Stock (HLTH) stake by 78% in Q4 2021, selling an estimated $275 and leaving 7 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #524.

Crescent Capital Consulting first reported a position in HLTH in Q3 2021 and has held it in 2 quarters since. 65 funds tracked by Wall St. Rank hold HLTH as of Q4 2021.

  • Crescent Capital Consulting held 7 shares of Cue Health Inc. Common Stock worth $0 as of Q4 2021.
  • Crescent Capital Consulting sold 25 Cue Health Inc. Common Stock shares in Q4 2021, an estimated $275.
  • Cue Health Inc. Common Stock made up ﹤0.01% of Crescent Capital Consulting's portfolio in Q4 2021, its #524 holding.
  • Crescent Capital Consulting first reported a position in Cue Health Inc. Common Stock in Q3 2021 and has held it in 2 quarters since.
  • 65 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q4 2021.

Based on Crescent Capital Consulting's 13F filing for Q4 2021, filed 18 Jan 2022.